Investigation of Melioidosis Using Blood Culture and Indirect Hemagglutination Assay Serology among Patients with Fever, Northern Tanzania
Authors:
- Michael J. MazeMMMichael J. Maze
- Mindy Glass ElrodMEMindy Glass Elrod
- Holly M. BiggsHBHolly M. Biggs
- John BonnewellJBJohn Bonnewell
- Manuela CarugatiMCManuela Carugati
- Alex R. HoffmasterAHAlex R. Hoffmaster
- Bingileki F. LwezaulaBLBingileki F. Lwezaula
- Deng B. MadutDMDeng B. Madut
- Venance P. MaroVMVenance P. Maro
- Blandina T. MmbagaBlandina T. Mmbaga
- Anne B. MorrisseyAMAnne B. Morrissey
Open Access
- 2 December 2020
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 103 (6) , 2510-2514
Abstract
Prediction models indicate that melioidosis may be common in parts of East Africa, but there are few empiric data. We evaluated the prevalence of melioidosis among patients presenting with fever to hospitals in Tanzania. Patients with fever were enrolled at two referral hospitals in Moshi, Tanzania, during 2007–2008, 2012–2014, and 2016–2019. Blood was collected from participants for aerobic culture. Bloodstream isolates were identified by conventional biochemical methods. Non–glucose-fermenting Gram-negative bacilli were further tested using a Burkholderia pseudomallei latex agglutination assay. Also, we performed B. pseudomallei indirect hemagglutination assay (IHA) serology on serum samples from participants enrolled from 2012 to 2014 and considered at high epidemiologic risk of melioidosis on the basis of admission within 30 days of rainfall. We defined confirmed melioidosis as isolation of B. pseudomallei from blood culture, probable melioidosis as a ≥ 4-fold rise in antibody titers between acute and convalescent sera, and seropositivity as a single antibody titer ≥ 40. We enrolled 3,716 participants and isolated non-enteric Gram-negative bacilli in five (2.5%) of 200 with bacteremia. As none of these five isolates was B. pseudomallei, there were no confirmed melioidosis cases. Of 323 participants tested by IHA, 142 (44.0%) were male, and the median (range) age was 27 (0–70) years. We identified two (0.6%) cases of probable melioidosis, and 57 (17.7%) were seropositive. The absence of confirmed melioidosis from 9 years of fever surveillance indicates melioidosis was not a major cause of illness.Keywords
This publication has 28 references indexed in Scilit:
- Melioidosis in Traveler from Africa to SpainEmerging Infectious Diseases, 2013
- Human Melioidosis, Malawi, 2011Emerging Infectious Diseases, 2013
- Surprisingly Low Seroprevalence of Burkholderia pseudomallei in Exposed Healthy Adults in the Darwin Region of Tropical Australia Where Melioidosis Is Highly EndemicClinical and Vaccine Immunology, 2013
- Systematic Review and Consensus Guidelines for Environmental Sampling of Burkholderia pseudomalleiPLOS Neglected Tropical Diseases, 2013
- Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Rapid Identification of Burkholderia pseudomallei: Importance of Expanding Databases with Pathogens Endemic to Different LocalitiesJournal of Clinical Microbiology, 2012
- Humoral Immune Responses in a Human Case of GlandersClinical and Vaccine Immunology, 2012
- Defining the True Sensitivity of Culture for the Diagnosis of Melioidosis Using Bayesian Latent Class ModelsPLOS ONE, 2010
- Burkholderia pseudomalleiMisidentified by Automated SystemEmerging Infectious Diseases, 2009
- Accuracy of Burkholderia pseudomallei Identification Using the API 20NE System and a Latex Agglutination TestJournal of Clinical Microbiology, 2007
- Use of Antigens Derived from Burkholderia pseudomallei , B. thailandensis , and B. cepacia in the Indirect Hemagglutination Assay for MelioidosisClinical and Vaccine Immunology, 2007